Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014)
Clinical trial NCT02115347 · COMPLETED
Trial details
- NCT number
- NCT02115347
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-19
- Primary completion
- 2015-01-10
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.